# China NMPA Drug Inspection - Zhanjiang Dadi Traditional Chinese Medicine Pieces Factory Co., Ltd. - Processed Polygonum multiflorum

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhanjiang-dadi-traditional-chinese-medicine-pieces-factory-co-ltd/7e65241b-a697-4903-8c30-cbaeb18223fd/
Source feed: China

> China NMPA drug inspection for Zhanjiang Dadi Traditional Chinese Medicine Pieces Factory Co., Ltd. published December 13, 2019. Drug: Processed Polygonum multiflorum. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 8, 2019)
- Company Name: Zhanjiang Dadi Traditional Chinese Medicine Pieces Factory Co., Ltd.
- Publication Date: 2019-12-13
- Drug Name: Processed Polygonum multiflorum
- Inspection Finding: The non-compliance is due to the [content determination] of free anthraquinones.
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/zhanjiang-dadi-traditional-chinese-medicine-pieces-factory-co-ltd/073206f5-38aa-4f60-8c33-d44c77c3e1e3/